Combined expression of HLA-DR antigen and proliferating cell nuclear antigen correlate with colorectal cancer prognosis

Oncology

Volumn 55, Issue 4, 1998, Pages 326-333

  Kunihiro, Masaki ^a   Tanaka, Shinji ^a   Haruma, Ken ^a   Yoshihara, Masaharu ^a   Sumii, Koji ^a   Kajiyama, Goro ^a   Shimamoto, Fumio ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Colorectal cancer; HLA DR antigen; Prognosis; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE; HLA DR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL ANALYSIS;

EID: 0031811846     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011870     Document Type: Article

References (36)

1. Brandtzaeg P, Halstensen TS, Kett K, Kiajci P, Kvale D, Rognum TO, Scott H, Sollid LM: Immunology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989; 97:1562-1584.
2. Teh M, Lee YS: HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma. Cancer 1992;69:1104-1107.
3. Sadanaga N, Kuwano H, Watanabe M, Maekawa S, Mori M, Sugimachi K: Local immune response to tumor invasion in esophageal squamous cell carcinoma. Cancer 1994;74:586-591.
4. Jackson PA, Green MA, Marks CG, King RJB, Hubbard R, Cook MG: Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas. Gut 1996;38:85-89.
5. Steinman R: Dendritic cells. Transplantation 1981;31:151-155.
6. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ: The detailed distribution of MHC class II antigens in normal human organs. Transplantation 1984;38:293-298.
7. Unanue ER: Antigen-presenting function of the macrophage. Annu Rev Immunol 1984;2: 293-298.
8. Concha A, Esteban F, Cabrera A, Ruiz-Cabello F, Garrio F: Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Cancer Biol 1991;2:47-54.
9. Rossi ML, Crus Sanchez F, Hughes JT, Esiri MM, Coakham HB: Immunocytochemical study of cellular immune response in meningiomas. J Clin Pathol 1988;41:314-319.
10. Ziai MR, Imberti L, Tongson A, Ferrone S: Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon. Cancer Res 1985;45:5877.
11. Hilton DA, West KP: An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer 1990;66:1154-1157.
12. Ma XC, Hattori T, Kushima R, Terata N, Kodama M: Expression of HLA class II antigen in gastric carcinomas. Acta Oncol 1994;33: 187-190.
13. Gutierrez J, Lopez-Novet MA, Cabrera T, Olivia R, Esquivias J, Ruiz-Cabello F, Garrido F: Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: Relation with malignancy and invasiveness. Exp Clin Immunogenet 1987;4:144-152.
14. Andersen SN, Rognum TO, Lund E, Meling GI, Hauge S: Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer 1993;68:80-85.
15. Morita M, Tanaka K, Kawanishi H, Tsuji M, Ookusa T, Takada H, Okamura A, Hioki K: Immunohistochemically demonstrated expression of HLA-DR antigen in colorectal adenocarcinomas and its relation to clinicopathological features. J Surg Oncol 1995;59:233-238.
16. Lazaris AC, Theodoropoulos GE, Davaris PS, Panoussopoulos D, Nakopoulou L, Kittas C, Golematis BC: Heat shock protein 70 and HLA-DR molecules tissue expression. Dis Colon Rectum 1995;38:739-745.
17. Festenstein H: The biological consequences of altered MHC expression on tumors. Br Med Bull 1987;43:217-227.
18. Cells JE, Cells A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin/proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci USA 1985;82:3262-3266.
19. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
20. Zuber M, Tan EM, Ryoji M: Involvement of proliferating cell nuclear antigen (cyclin) in DNA replication in living cells. Mol Cell Biol 1989;9:57-66.
21. Jaskulski D, de Kiel JK, Mercer WE, Calabretta B, Baserga R: Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 1988;240:1544-1546.
22. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G: Proliferating cell nuclear antigen (PCNA) expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 1994;73:575-579.
23. Tanaka S, Haruma K, Tatsuta S, Hiraga Y, Teixeira CR, Shimamoto F, Yoshihara M, Sumii K, Kajiyama G: Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma. Oncology 1995;52:134-139.
24. Teixeira CR, Tanaka S. Haruma K, Yoshihara M, Sumii K, Kajiyama G. Shimamoto F: The clinical significance of the histologie subclassification of colorectal carcinoma. Oncology 1993;50:495-499.
25. Tanaka S, Hamura K, Teixeira CR, Tatsuta S, Ohtsu N, Hiraga Y, Yosihara M, Sumii K, Kajiyama G, Shimamoto F: Endoscopie treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 1995; 30:710-717.
26. Jass JR, Sobin LH: Histological typing of intestinal tumors; in WHO (ed): International Histological Classification of Tumors, ed 2. Berlin, Springer, 1989.
27. Japanese Research Society for Cancer of Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, ed 5. Tokyo, Kanahara, 1994.
28. Horie Y, Chiba M, Iizuka M, Masamune O: Class II (HLA-DR, -DP, and -DQ) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine. Gastroenterol Jpn 1990;25:575-584.
29. Degener T, Monburg F, Möller P: Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma. Virchows Arch A Pathol Anat Histopathol 1988;412:315-322.
30. Ferrone S, Fukusato T, Gerber MA, Pullano TG, Ruiter DJ, Thung SH, Van Den Ingh HF: Class I and class II HLA antigens in colorectal and liver carcinomas. GNAA Monogr Cancer Res 1986;31:75-83.
31. Brandtzaeg P, Sollid LM, Thrane PS: Lymphoepithelial interactions in the mucosal immune system. Gut 1988;29:1116-1130.
32. Gioufas AF, Moutsopoulos CM: Immunology, ed 1. Athens, Litsas, 1991, pp 141-148.
33. Rook G: Cell-mediated immune reactions; in Roit IM, Brostoff J, Male D (eds): Immunology, ed 3. St Louis, Mosby Yearbook, 1993.
34. Suzuki Y, Ohtani H, Mizoi T, Takeha S, Shiiba K, Matsuno S, Nagura H: Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res 1995;86: 585-593.
35. Esteban F, Ruiz-Cabello F, Concha A, Perez-Ayala M, Sanchez-Rozas JA, Garrido F: HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis 1990;8:319-328.
36. Zaloudik J, Moore M, Ghosh AK, Mechl Z, Rejthar A: DNA content and MHC class II antigen expression in malignant melanoma: Clinical course. J Clin Pathol 1988;41:1078-1084.